Originally published August 6 2005
Naturally-occurring enzyme can prevent liver cancer
by Mike Adams, the Health Ranger, NaturalNews Editor
A study done by Canadian scientists states that liver cancer is caused by the lack of a naturally-occurring enzyme, Plk4, in patients.
Canadian researchers say they've determined primary liver cancer is much more likely to occur when a naturally occurring enzyme is in short supply.
The team of scientists at Mount Sinai Hospital's Samuel Lunenfeld Research Institute in Toronto found the likelihood of hepatoma, or primary liver cancer, increases substantially when half the normal amount of an enzyme called Plk4 is present.
Furthermore, they said 60 percent of patients with hepatoma were missing one copy of the Plk4 gene in their cancers.
The genetic basis for hepatoma has not previously been extensively explored.
Our study indicates that loss of one copy of Plk4 is a major risk factor for primary liver cancer, said Dr. Carol Swallow, a surgical oncologist at the hospital and an associate professor of surgery at the University of Toronto.
The study is published in the August edition of the science journal, Nature Genetics.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml